Scope of dermatological practice among transgenders seeking cosmetic advice
DOI:
https://doi.org/10.18203/2349-3933.ijam20241632Keywords:
Transgender, Steroid, Whitening, Dermatological adviceAbstract
Transgender women are persons who are assigned male at birth, but who identify themselves as women. They aspire to display female characteristics both in appearance and attitude. Transgender women try to exhibit their female sexuality through the extensive usage of cosmetological interventions such as epilation of facial hair, control of acne, whitening treatments and excessive usage of makeup on face as the face serves as the part of body that helps to project their sexual characteristics. The prolonged and inappropriate usage of such interventions can lead to complications for which these group of individuals seek Dermatologic advice. Due to the rampant usage of steroid containing creams by our population in general and transgender community in particular as a means to overcome body dysmorphia, dermatologists have the responsibility to give proper advice regarding the complications following any cosmetological interventions. We report three transgender females who came to the OPD with skin thinning, acne, hypertrichosis and telangiectasia following the usage of topical steroid containing facial whitening creams.
Metrics
References
Hijras/Transgender in India: HIV, human rights and social exclusion. Available at: https://www.undp. org/india/publications/hijras/transgender-india-hiv-human-rights-and-social-exclusion. Accessed 20 February 2024.
Burry JN. Topical drug addiction: Adverse effects of fluorinated corticosteroid creams ointments. Med J Aust. 1973;1:393-6.
Coondoo A, Phiske M, Verma S, Lahiri K. Side-effects of topical steroids: A long overdue revisit. Indian Dermatol Online J. 2014;5(4):416-25.
Saraswat A, Lahiri K, Chatterjee M, Barua S, Coondoo A, Mittal A, et al. Topical corticosteroid abuse on the face: A prospective, multicenter study of dermatology outpatients. Indian J Dermatol Venereol Leprol. 2011;77:160-6.
Lazar, M.; De La Garza, H.; Vashi, N.A. Exogenous Ochronosis: Characterizing a Rare Disorder in Skin of Color. J Clin Med. 2023;12:4341.
Findlay GH, Morrison JG, Simson IW. Exogenous ochronosis and pigmented colloid milium from hydroquinone bleaching creams. Br J Dermatol. 1975;93:613-22.
Dogliotti M, Leibowitz M. Granulomatous ochronosis A cosmetic-induced skin disorder in blacks. S Afr Med J. 1979;56:757-60.
Phillips JI, Isaacson C, Carman H. Ochronosis in black South Africans who used skin lighteners. Am J Dermatopathol. 1986;8:14-21.
Hardwick N, Van Gelder LW, Van der Merwe CA, Van der Merwe MP. Exogenous ochronosis: An epidemiological study. Br J Dermatol. 1989;120:229-38.
Jordaan HF, Van Niekerk DJ. Transepidermal elimination in exogenous ochronosis. A report of two cases. Am J Dermatopathol. 1991;13:418-24.
Ragmanauskaite L, Kahn B, Ly B, Yeung H. Acne and the lesbian, gay, bisexual, or transgender teenager. Dermatol Clin. 2020;38:219-26.
Giltay EJ, Gooren LJ. Effects of sex steroid deprivation/administration on hair growth and skin sebum production in transsexual males and females. J Clin Endocrinol Metab. 2000;85:2913-21.
Wendelin DS, Pope DN, Mallory SB. Hypertrichosis. J Am Acad Dermatol. 2003;48(2):161-82.
Suh DH, Oh H, Lee SJ, Kim HJ, Ryu HJ. Relationship between acne and the use of cosmetics: Results of a questionnaire study in 539 Korean individuals. J Cosmet Dermatol. 2021;20(7):2172-8.
Lahiri K, Coondoo A. Topical steroid damaged/dependent face (TSDF): an entity of cutaneous pharmacodependence. Indian J Dermatol. 2016;61(3):265-72.
Jain A, Pai SB, Shenoi SD. Exogenous ochronosis. Indian J Dermatol Venereol Leprol. 2013;79:522-3.